CN Patent

CN110290797A — 用于预防和治疗真菌感染的单剂量方法

Assigned to Seachaid Pharmaceuticals LLC · Expires 2019-09-27 · 7y expired

What this patent protects

本文提供了在有此需要的人受试者中治疗、减轻或预防真菌感染或其相关病况的方法。该方法包括施用单剂量的包含CD101和任何药学上可接受的赋形剂或由其组成的药物组合物，其中所述单剂量治疗基本上减少或消除了真菌感染。

USPTO Abstract

本文提供了在有此需要的人受试者中治疗、减轻或预防真菌感染或其相关病况的方法。该方法包括施用单剂量的包含CD101和任何药学上可接受的赋形剂或由其组成的药物组合物，其中所述单剂量治疗基本上减少或消除了真菌感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN110290797A
Jurisdiction
CN
Classification
—
Expires
2019-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Seachaid Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.